This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugates, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugates.

The Antibody Drug Conjugates market size considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Drug Conjugates market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug Conjugates manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Antibody Drug Conjugates market size in 2023 is 8460.0 million US dollars, and it is expected to be 26159.9 million US dollars by 2030, with a compound annual growth rate of 17.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Antibody Drug Conjugates market include Takeda Pharmaceutical Company Limited, Hoffmann-La Roche Ltd., Pfizer, Inc., AstraZeneca, and Gilead Sciences, Inc.. The share of the top 3 players in the Antibody Drug Conjugates market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Antibody Drug Conjugates market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. CD30 Antibodies accounted for XX% of Antibody Drug Conjugates market in 2023. HER2 Antibodies share of XX%.
Hospitals and Speciality Cancer Centers accounted for XX% of the Antibody Drug Conjugates market in 2023. Biotechnology and Pharmaceutical Companies accounts for XX%.

Chapter Outline
Chapters 1-2: Introduces the product overview, market scope, product classification, application, and regional division.
Chapter 3: Analysis of the competitive environment of Antibody Drug Conjugates market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapter 4: Provide global Antibody Drug Conjugates market value, volume and price data by region.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Antibody Drug Conjugates market country segmentation data.
Chapter 10: Analyzes the main companies in the Antibody Drug Conjugates industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapter 11: Analyzes the Antibody Drug Conjugates manufacturing cost, including raw material analysis, manufacturing cost structure, and market dynamics.
Chapter 12: Analyzes the Antibody Drug Conjugates industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Takeda Pharmaceutical Company Limited
Hoffmann-La Roche Ltd.
Pfizer, Inc.
AstraZeneca
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Seagen, Inc.
Daiichi Sankyo Company, Limited
GlaxoSmithKline plc
Adc Therapeutics Saa

Types list
CD30 Antibodies
HER2 Antibodies
Other Target Types

Application list
Hospitals and Speciality Cancer Centers
Biotechnology and Pharmaceutical Companies
Other End Users

Table of Content

1 Antibody Drug Conjugates Market Overview
1.1 Antibody Drug Conjugates Product Description
1.2 Antibody Drug Conjugates Market Segment by Type
1.3 Global Antibody Drug Conjugates Market Size by Type
1.3.1 Global Antibody Drug Conjugates Market Size Overview by Type
1.3.2 Global Antibody Drug Conjugates Historic Market Size Review by Type
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Drug Conjugates Sales Breakdown by Type
1.4.2 Europe Antibody Drug Conjugates Sales Breakdown by Type
1.4.3 Asia-Pacific Antibody Drug Conjugates Sales Breakdown by Type
1.4.4 Latin America Antibody Drug Conjugates Sales Breakdown by Type
1.4.5 Middle East and Africa Antibody Drug Conjugates Sales Breakdown by Type
2 Global Antibody Drug Conjugates by Application
2.1 Antibody Drug Conjugates Market Segment by Application
2.2 Global Antibody Drug Conjugates Market Size by Application
2.2.1 Global Antibody Drug Conjugates Market Size Overview by Application
2.2.2 Global Antibody Drug Conjugates Historic Market Size Review by Application
2.3 Key Regions Market Size Segment by Application
2.3.1 North America Antibody Drug Conjugates Sales Breakdown by Application
2.3.2 Europe Antibody Drug Conjugates Sales Breakdown by Application
2.3.3 Asia-Pacific Antibody Drug Conjugates Sales Breakdown by Application
2.3.4 Latin America Antibody Drug Conjugates Sales Breakdown by Application
2.3.5 Middle East and Africa Antibody Drug Conjugates Sales Breakdown by Application
3 Antibody Drug Conjugates Status and Outlook by Region
3.1 Global Antibody Drug Conjugates Market Size and CAGR by Region: 2019 VS 2024 VS 2030
3.2 Global Antibody Drug Conjugates Historic Market Size by Region
3.2.1 Global Antibody Drug Conjugates Sales in Volume by Region
3.2.2 Global Antibody Drug Conjugates Sales in Value by Region
3.2.3 Global Antibody Drug Conjugates Sales Price and Gross Margin
3.3 Global Antibody Drug Conjugates Forecasted Market Size by Region
3.3.1 Global Antibody Drug Conjugates Sales in Volume by Region
3.3.2 Global Antibody Drug Conjugates Sales in Value by Region
3.3.3 Global Antibody Drug Conjugates Sales Price and Gross Margin
4 Global Antibody Drug Conjugates Market Competition by Company
4.1 Global Top Players by Antibody Drug Conjugates Sales
4.2 Global Top Players by Antibody Drug Conjugates Revenue
4.3 Global Top Players Antibody Drug Conjugates Price
4.4 Global Top Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type
4.5 Antibody Drug Conjugates Market Competitive Situation and Trends
4.5.1 Antibody Drug Conjugates Market Concentration Rate
4.5.2 Global 3 and 6 Largest Manufacturers by Antibody Drug Conjugates Sales and Revenue in 2023
4.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugates as of 2023)
4.7 Date of Key Manufacturers Enter into Antibody Drug Conjugates Market
4.8 Key Manufacturers Antibody Drug Conjugates Product Offered
4.9 Mergers & Acquisitions, Expansion
5 North America Antibody Drug Conjugates by Country
5.1 North America Antibody Drug Conjugates Historic Market Size by Country
5.1.1 North America Antibody Drug Conjugates Sales in Volume by Country
5.1.2 North America Antibody Drug Conjugates Sales in Value by Country
5.2 North America Antibody Drug Conjugates Forecasted Market Size by Country
5.2.1 North America Antibody Drug Conjugates Sales in Volume by Country
5.2.2 North America Antibody Drug Conjugates Sales in Value by Country
6 Europe Antibody Drug Conjugates by Country
6.1 Europe Antibody Drug Conjugates Historic Market Size by Country
6.1.1 Europe Antibody Drug Conjugates Sales in Volume by Country
6.1.2 Europe Antibody Drug Conjugates Sales in Value by Country
6.2 Europe Antibody Drug Conjugates Forecasted Market Size by Country
6.2.1 Europe Antibody Drug Conjugates Sales in Volume by Country
6.2.2 Europe Antibody Drug Conjugates Sales in Value by Country
7 Asia-Pacific Antibody Drug Conjugates by Country
7.1 Asia-Pacific Antibody Drug Conjugates Historic Market Size by Country
7.1.1 Asia-Pacific Antibody Drug Conjugates Sales in Volume by Country
7.1.2 Asia-Pacific Antibody Drug Conjugates Sales in Value by Country
7.2 Asia-Pacific Antibody Drug Conjugates Forecasted Market Size by Country
7.2.1 Asia-Pacific Antibody Drug Conjugates Sales in Volume by Country
7.2.2 Asia-Pacific Antibody Drug Conjugates Sales in Value by Country
8 Latin America Antibody Drug Conjugates by Country
8.1 Latin America Antibody Drug Conjugates Historic Market Size by Country
8.1.1 Latin America Antibody Drug Conjugates Sales in Volume by Country
8.1.2 Latin America Antibody Drug Conjugates Sales in Value by Country
8.2 Latin America Antibody Drug Conjugates Forecasted Market Size by Country
8.2.1 8.2.1 Latin America Antibody Drug Conjugates Sales in Volume by Country
8.2.2 8.2.2 Latin America Antibody Drug Conjugates Sales in Value by Country
9 Middle East and Africa Antibody Drug Conjugates by Country
9.1 Middle East and Africa Antibody Drug Conjugates Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Drug Conjugates Sales in Volume by Country
9.1.2 Middle East and Africa Antibody Drug Conjugates Sales in Value by Country
9.2 Middle East and Africa Antibody Drug Conjugates Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Drug Conjugates Sales in Volume by Country
9.2.2 Middle East and Africa Antibody Drug Conjugates Sales in Value by Country
10 Manufacturers Profiles
10.1 Takeda Pharmaceutical Company Limited
10.1.1 Takeda Pharmaceutical Company Limited Information
10.1.2 Business Overview
10.1.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.1.4 Antibody Drug Conjugates Products Offered
10.1.5 Takeda Pharmaceutical Company Limited Recent Development
10.2 Hoffmann-La Roche Ltd.
10.2.1 Hoffmann-La Roche Ltd. Information
10.2.2 Business Overview
10.2.3 Hoffmann-La Roche Ltd. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.2.4 Antibody Drug Conjugates Products Offered
10.2.5 Hoffmann-La Roche Ltd. Recent Development
10.3 Pfizer, Inc.
10.3.1 Pfizer, Inc. Information
10.3.2 Business Overview
10.3.3 Pfizer, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.3.4 Antibody Drug Conjugates Products Offered
10.3.5 Pfizer, Inc. Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Information
10.4.2 Business Overview
10.4.3 AstraZeneca Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.4.4 Antibody Drug Conjugates Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Gilead Sciences, Inc.
10.5.1 Gilead Sciences, Inc. Information
10.5.2 Business Overview
10.5.3 Gilead Sciences, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.5.4 Antibody Drug Conjugates Products Offered
10.5.5 Gilead Sciences, Inc. Recent Development
10.6 Astellas Pharma, Inc.
10.6.1 Astellas Pharma, Inc. Information
10.6.2 Business Overview
10.6.3 Astellas Pharma, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.6.4 Antibody Drug Conjugates Products Offered
10.6.5 Astellas Pharma, Inc. Recent Development
10.7 Seagen, Inc.
10.7.1 Seagen, Inc. Information
10.7.2 Business Overview
10.7.3 Seagen, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.7.4 Antibody Drug Conjugates Products Offered
10.7.5 Seagen, Inc. Recent Development
10.8 Daiichi Sankyo Company, Limited
10.8.1 Daiichi Sankyo Company, Limited Information
10.8.2 Business Overview
10.8.3 Daiichi Sankyo Company, Limited Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.8.4 Antibody Drug Conjugates Products Offered
10.8.5 Daiichi Sankyo Company, Limited Recent Development
10.9 GlaxoSmithKline plc
10.9.1 GlaxoSmithKline plc Information
10.9.2 Business Overview
10.9.3 GlaxoSmithKline plc Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.9.4 Antibody Drug Conjugates Products Offered
10.9.5 GlaxoSmithKline plc Recent Development
10.10 Adc Therapeutics Saa
10.10.1 Adc Therapeutics Saa Information
10.10.2 Business Overview
10.10.3 Adc Therapeutics Saa Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin
10.10.4 Antibody Drug Conjugates Products Offered
10.10.5 Adc Therapeutics Saa Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Drug Conjugates Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Drug Conjugates Industrial Chain Analysis
11.4 Antibody Drug Conjugates Market Dynamics
11.4.1 Antibody Drug Conjugates Industry Trends
11.4.2 Antibody Drug Conjugates Growth Drivers
11.4.3 Antibody Drug Conjugates Market Challenges
11.4.4 Antibody Drug Conjugates Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Drug Conjugates Distributors
12.3 Antibody Drug Conjugates Downstream Customers
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer

List of Tables and Figures

Figure Global Antibody Drug Conjugates Market Size Overview by Type
Table Global Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Table Global Antibody Drug Conjugates Sales Breakdown in Value, by Type
Table Global Antibody Drug Conjugates Average Selling Price (ASP) by Type
Table Global Antibody Drug Conjugates Sales Breakdown in Volume, by Type (2024-2030)
Table Global Antibody Drug Conjugates Sales Breakdown in Value, by Type (2024-2030)
Table Global Antibody Drug Conjugates Average Selling Price (ASP) by Type (2024-2030)
Table North America Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Table Europe Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Table Asia-Pacific Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Table Latin America Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Table Middle East and Africa Antibody Drug Conjugates Sales Breakdown in Volume, by Type
Figure Global Antibody Drug Conjugates Market Size Overview by Application
Table Global Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Global Antibody Drug Conjugates Sales Breakdown in Value, by Application
Table Global Antibody Drug Conjugates Average Selling Price (ASP) by Application
Table Global Antibody Drug Conjugates Sales Breakdown in Volume, by Application (2024-2030)
Table Global Antibody Drug Conjugates Sales Breakdown in Value, by Application (2024-2030)
Table Global Antibody Drug Conjugates Average Selling Price (ASP) by Application (2024-2030)
Table North America Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Europe Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Asia-Pacific Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Latin America Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Middle East and Africa Antibody Drug Conjugates Sales Breakdown in Volume, by Application
Table Global Antibody Drug Conjugates Market Size and CAGR by Region: 2019 VS 2024 VS 2030
Table Global Antibody Drug Conjugates Sales in Volume by Region
Table Global Antibody Drug Conjugates Sales in Value by Region
Table Global Antibody Drug Conjugates Sales Price and Gross Margin
Table Global Antibody Drug Conjugates Sales in Volume by Region
Table Global Antibody Drug Conjugates Sales in Value by Region
Table Global Antibody Drug Conjugates Sales Price and Gross Margin
Table Global Top Players by Antibody Drug Conjugates Sales
Table Global Top Players by Antibody Drug Conjugates Revenue
Table Global Top Players by Antibody Drug Conjugates Price
Table Global Top Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type
Table Antibody Drug Conjugates Market Concentration Rate
Figure Global 5 and 10 Largest Manufacturers by Antibody Drug Conjugates Sales and Revenue in 2023
Table Date of Key Manufacturers Enter into Antibody Drug Conjugates Market
Table Key Manufacturers Antibody Drug Conjugates Product Offered
Table Mergers & Acquisitions, Expansion Plans
Table North America Antibody Drug Conjugates Sales in Volume by Country
Table North America Antibody Drug Conjugates Sales in Value by Country
Table North America Antibody Drug Conjugates Sales in Volume by Country
Table North America Antibody Drug Conjugates Sales in Value by Country
Table Europe Antibody Drug Conjugates Sales in Volume by Country
Table Europe Antibody Drug Conjugates Sales in Value by Country
Table Europe Antibody Drug Conjugates Sales in Volume by Country
Table Europe Antibody Drug Conjugates Sales in Value by Country
Table Asia-Pacific Antibody Drug Conjugates Sales in Volume by Country
Table Asia-Pacific Antibody Drug Conjugates Sales in Value by Country
Table Asia-Pacific Antibody Drug Conjugates Sales in Volume by Country
Table Asia-Pacific Antibody Drug Conjugates Sales in Value by Country
Table Latin America Antibody Drug Conjugates Sales in Volume by Country
Table Latin America Antibody Drug Conjugates Sales in Value by Country
Table Latin America Antibody Drug Conjugates Sales in Volume by Country
Table Latin America Antibody Drug Conjugates Sales in Value by Country
Table Middle East and Africa Antibody Drug Conjugates Sales in Volume by Country
Table Middle East and Africa Antibody Drug Conjugates Sales in Value by Country
Table Middle East and Africa Antibody Drug Conjugates Sales in Volume by Country
Table Middle East and Africa Antibody Drug Conjugates Sales in Value by Country
Table Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Takeda Pharmaceutical Company Limited Sales and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Takeda Pharmaceutical Company Limited Recent Development
Table Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base
Table Hoffmann-La Roche Ltd. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Hoffmann-La Roche Ltd. Sales and Growth Rate
Figure Hoffmann-La Roche Ltd. Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Hoffmann-La Roche Ltd. Recent Development
Table Pfizer, Inc. Basic Information, Manufacturing Base
Table Pfizer, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Pfizer, Inc. Sales and Growth Rate
Figure Pfizer, Inc. Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Pfizer, Inc. Recent Development
Table AstraZeneca Basic Information, Manufacturing Base
Table AstraZeneca Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure AstraZeneca Sales and Growth Rate
Figure AstraZeneca Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table AstraZeneca Recent Development
Table Gilead Sciences, Inc. Basic Information, Manufacturing Base
Table Gilead Sciences, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Sales and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Gilead Sciences, Inc. Recent Development
Table Astellas Pharma, Inc. Basic Information, Manufacturing Base
Table Astellas Pharma, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Astellas Pharma, Inc. Sales and Growth Rate
Figure Astellas Pharma, Inc. Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Astellas Pharma, Inc. Recent Development
Table Seagen, Inc. Basic Information, Manufacturing Base
Table Seagen, Inc. Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Seagen, Inc. Sales and Growth Rate
Figure Seagen, Inc. Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Seagen, Inc. Recent Development
Table Daiichi Sankyo Company, Limited Basic Information, Manufacturing Base
Table Daiichi Sankyo Company, Limited Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Daiichi Sankyo Company, Limited Sales and Growth Rate
Figure Daiichi Sankyo Company, Limited Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Daiichi Sankyo Company, Limited Recent Development
Table GlaxoSmithKline plc Basic Information, Manufacturing Base
Table GlaxoSmithKline plc Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure GlaxoSmithKline plc Sales and Growth Rate
Figure GlaxoSmithKline plc Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table GlaxoSmithKline plc Recent Development
Table Adc Therapeutics Saa Basic Information, Manufacturing Base
Table Adc Therapeutics Saa Antibody Drug Conjugates Sales, Price, Revenue, Gross Margin (2019-2024)
Figure Adc Therapeutics Saa Sales and Growth Rate
Figure Adc Therapeutics Saa Revenue Market Share 2019-2024
Table Antibody Drug Conjugates Products Offered
Table Adc Therapeutics Saa Recent Development
Table Key Raw Materials Price
Table Key Suppliers of Raw Materials
Figure Proportion of Manufacturing Cost Structure
Table Antibody Drug Conjugates Chain Analysis
Figure Marketing Channel
Table Major Distributors of Antibody Drug Conjugates with Contact Information
Table Major Customers of Antibody Drug Conjugates with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report